India faces a dire shortage of stem cell donors, even as 50,000 new cases of blood cancer and haematological diseases are detected every year.
The landscape of cancer treatment in India is undergoing a transformative shift. With cutting-edge therapies like hematopoietic stem cell transplants (HSCTs) offering renewed hope for patients with blood cancers and genetic disorders, the country stands at a pivotal moment. However, despite its vast population, India faces a dire shortage of stem cell donors, leaving thousands of patients in limbo.
As Dr Pradeep Mahajan, Regenerative Medicine Researcher and Founder, StemRx Hospital and Research Centre, points out, “The need for hematopoietic stem cell donors in India has never been greater. With over 50,000 new cases of blood cancers and hematological diseases each year, the mismatch between patients and potential donors is a growing crisis.”
With Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) achieving a milestone of 200 successful transplants in 2024 and alternative treatments like CAR T-cell therapy gaining traction, the road ahead presents both challenges and opportunities.
The critical need for Stem Cell Donors in India
Despite having a population exceeding 1.4 billion, India’s stem cell donor registry is critically underdeveloped, covering only 0.01 per cent of the population. The probability of finding a matching donor is as low as 1 in 10,000 to 1 in 20,000, resulting in 83 per cent of patients failing to secure a viable match.
The situation is particularly dire for those battling conditions like thalassemia major, which requires lifelong blood transfusions unless treated with a stem cell transplant. The numbers paint a grim picture—over 100,000 new cases of blood cancers are diagnosed annually, while more than 10,000 children are born with thalassemia major each year.
——————————————————————————————————————
The numbers paint a grim picture—over 100,000 new cases of blood cancers are diagnosed annually, while more than 10,000 children are born with thalassemia major each year.
—————————————————————————————————————–
Patrick Paul, Spokesperson, DKMS Foundation India, emphasises, “India’s challenge is not just about increasing donor numbers, but also ensuring that the registry reflects the country’s vast genetic diversity. A collaborative, multi-stakeholder approach involving policy advocacy, corporate engagement, and digital awareness is the key to bridging this gap.”
To meet demand by 2030, India will need to register 200,000 new donors annually, requiring targeted recruitment strategies.
Expanding registries: Challenges and potential solutions
1. Public awareness & debunking myths
One of the primary barriers to donor registration is misconceptions about the procedure. Many believe that stem cell donation is painful, involves surgery, or carries long-term health risks. However, modern peripheral blood stem cell (PBSC) donation is a minimally invasive, safe, and painless procedure.
Social media campaigns like #GiftLife, which generated 2 million impressions in 2024, is crucial in changing public perceptions. Celebrity endorsements, influencer-led initiatives, and real-life success stories can further encourage participation.
2. Corporate & institutional engagement
Universities and workplaces offer high-impact environments for donor recruitment. Patrick Paul highlights, “Young donors have the highest transplant success rates. Integrating donor education into college events and corporate CSR initiatives can dramatically boost registry numbers.”
Many global registries, such as Germany’s ZKRD (19 per cent registered donors) and the United States (5 per cent registered donors), thrive on corporate and institutional engagement. India must replicate this model through collaborations with educational institutions, companies, and government programs.
3. Leveraging technology for registration & matching
With swab kit registrations costing as little as ₹0–1,800, online platforms can simplify the registration process. Mailing swab kits directly to individuals and utilizing AI-driven genetic matching systems can accelerate the donor search, reducing patient wait times.
Further, India needs a National Stem Cell Diversity Project, similar to Europe’s central donor registry, to genotype 100,000 donors by 2026. A well-integrated national registry will improve match rates and reduce patient mortality.
—————————————————————————————————————
Further, India needs a National Stem Cell Diversity Project, similar to Europe’s central donor registry, to genotype 100,000 donors by 2026.
————————————————————————————————————–
The economics of Advanced Cancer care: Cost vs. Accessibility
While HSCTs offer a 60–80 per cent success rate for conditions like leukemia and thalassemia, the cost barrier remains a significant concern. Autologous transplants (using a patient’s own cells) are widely available, but allogeneic transplants (requiring donor cells) remain expensive and limited in public hospitals.
While HSCTs offer a 60–80 per cent success rate for conditions like leukemia and thalassemia, the cost barrier remains a significant concern.
Dr Dinesh Bhurani, Director of Hemato-Oncology & Bone Marrow Transplant at RGCIRC, states, “Stem cell transplants are no longer experimental; they are a lifeline. However, accessibility is a challenge. Government subsidies, insurance coverage, and global partnerships are essential to make these treatments affordable.”
Possible solutions include:
- Public-private partnerships to subsidize costs
- Philanthropic collaborations for donor recruitment drives
- Regulatory reforms to standardize pricing across hospitals
A promising alternative for unmatched patients is CAR T-cell therapy, which involves reprogramming a patient’s own immune cells to fight cancer. Partnerships between stem cell banks and CAR T-cell companies can drive innovation while making therapies more cost-effective.
Scaling Stem Cell transplants in India
The success of RGCIRC’s transplant program underscores the potential for expansion. Haploidentical transplants, which require only a 50 per cent match, have increased patient survival rates, making transplants more accessible.
1. Expanding infrastructure beyond Metro cities
Currently, most transplant centers are concentrated in urban areas, limiting access for rural patients. The government must:
- Establish regional transplant centers
- Train specialized hematologists
- Improve stem cell banking facilities in Tier-II and Tier-III cities
2. Policy & regulatory reforms
A national stem cell donation policy can standardize:
- Donor compensation models
- Registry integration with global databases
- Public health initiatives to drive awareness
3. International Collaboration & Research
Lessons from countries with advanced stem cell programs can guide India’s growth. Establishing partnerships with global organizations like the WMDA (World Marrow Donor Association) can facilitate cross-border donor matching, increasing patient survival rates.
As India moves towards enhancing its donor registry and expanding transplant accessibility, a multi-pronged approach is required.
Dr. Pradeep Mahajan summarizes the urgency of the situation: “If India does not take immediate steps to strengthen its stem cell donation program, thousands of patients will continue to face unnecessary delays, reducing their chances of survival.”
Meanwhile, Patrick Paul emphasizes the need for collective action: “Creating a robust registry today will save lives tomorrow. The time to act is now.”
With sustained awareness, policy interventions, and corporate engagement, India can bridge the donor gap and make lifesaving transplants accessible to all. The next decade will determine whether stem cell therapy remains an elite privilege or becomes a universal right.
The question is—will India rise to the challenge.
